Page last updated: 2024-10-17

2-aminoadipic acid and Retinopathy of Prematurity

2-aminoadipic acid has been researched along with Retinopathy of Prematurity in 1 studies

2-Aminoadipic Acid: A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).
2-aminoadipic acid : An alpha-amino acid that is adipic acid bearing a single amino substituent at position 2. An intermediate in the formation of lysine.

Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhou, Y1
Xu, Y1
Zhang, X1
Huang, Q1
Tan, W1
Yang, Y1
He, X1
Yoshida, S1
Zhao, P1
Li, Y1

Other Studies

1 other study available for 2-aminoadipic acid and Retinopathy of Prematurity

ArticleYear
Plasma levels of amino acids and derivatives in retinopathy of prematurity.
    International journal of medical sciences, 2021, Volume: 18, Issue:15

    Topics: 2-Aminoadipic Acid; Amino Acids; Arginine; Biomarkers; Citrulline; Creatinine; Female; Humans; Infan

2021